Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence

Prostate cancer (PCa) is a common malignant type of urogenital tract tumor with poor prognosis. Despite therapeutic advances, the recurrence and mortality rates of PCa have continued to increase with poor prognoses. Pyroptosis, also known as inflammatory cell necrosis, is a recently identified type...

Full description

Bibliographic Details
Main Authors: Chun Li, Jie Zhu, Hexi Du, Chaozhao Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.814912/full
_version_ 1828337533860184064
author Chun Li
Chun Li
Chun Li
Chun Li
Jie Zhu
Hexi Du
Hexi Du
Hexi Du
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
author_facet Chun Li
Chun Li
Chun Li
Chun Li
Jie Zhu
Hexi Du
Hexi Du
Hexi Du
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
author_sort Chun Li
collection DOAJ
description Prostate cancer (PCa) is a common malignant type of urogenital tract tumor with poor prognosis. Despite therapeutic advances, the recurrence and mortality rates of PCa have continued to increase with poor prognoses. Pyroptosis, also known as inflammatory cell necrosis, is a recently identified type of programmed cell death that can regulate the invasiveness, differentiation, proliferation, and metastasis of tumor cells; thus, it has a profound effect on the prognosis of patients with tumors. However, the relationship between pyroptosis and PCa remains unclear. We first identified 25 pyroptosis-related genes (PRGs) that were differentially expressed between PCa tissues and matched normal tissues in The Cancer Genome Atlas (TCGA) cohort. Based on the expression levels of 25 PRGs, PCa patients were clearly divided into two clusters and 17 PRGs were found to be significantly different between the two clusters, suggesting probable roles for these genes in the progression and recurrence of PCa. Therefore, the GSE40272 dataset with recurrence follow-up information was used to verify their value. Univariate analysis suggested that 5/17 genes were associated with recurrence, the number of genes did not decrease after least absolute shrinkage and selection operator (LASSO) regression analysis, and 5 PRGs constituted the risk score formula. Low-risk and high-risk subgroups identified using the recurrence model showed different disease-free survival (DFS) times (P<0.001) and the risk score of five PRGs was a factor of independence for recurrence in patients with PCa. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses suggested that these pathways, and comprising PRGs might be closely related to carcinogenesis and invasion of tumors, tumor microenvironment, and immune response. In conclusion, the expression signatures of PRGs play an important role in predicting PCa recurrence.
first_indexed 2024-04-13T22:16:34Z
format Article
id doaj.art-93e096b59a934661bbbd2c31b32cace3
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T22:16:34Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-93e096b59a934661bbbd2c31b32cace32022-12-22T02:27:29ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-05-011210.3389/fonc.2022.814912814912Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer RecurrenceChun Li0Chun Li1Chun Li2Chun Li3Jie Zhu4Hexi Du5Hexi Du6Hexi Du7Chaozhao Liang8Chaozhao Liang9Chaozhao Liang10Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaInstitute of Urology, Anhui Medical University, Hefei, ChinaAnhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, ChinaCentral Hospital Affiliated to Shandong First Medical University, Jinan, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaInstitute of Urology, Anhui Medical University, Hefei, ChinaAnhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaInstitute of Urology, Anhui Medical University, Hefei, ChinaAnhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, ChinaProstate cancer (PCa) is a common malignant type of urogenital tract tumor with poor prognosis. Despite therapeutic advances, the recurrence and mortality rates of PCa have continued to increase with poor prognoses. Pyroptosis, also known as inflammatory cell necrosis, is a recently identified type of programmed cell death that can regulate the invasiveness, differentiation, proliferation, and metastasis of tumor cells; thus, it has a profound effect on the prognosis of patients with tumors. However, the relationship between pyroptosis and PCa remains unclear. We first identified 25 pyroptosis-related genes (PRGs) that were differentially expressed between PCa tissues and matched normal tissues in The Cancer Genome Atlas (TCGA) cohort. Based on the expression levels of 25 PRGs, PCa patients were clearly divided into two clusters and 17 PRGs were found to be significantly different between the two clusters, suggesting probable roles for these genes in the progression and recurrence of PCa. Therefore, the GSE40272 dataset with recurrence follow-up information was used to verify their value. Univariate analysis suggested that 5/17 genes were associated with recurrence, the number of genes did not decrease after least absolute shrinkage and selection operator (LASSO) regression analysis, and 5 PRGs constituted the risk score formula. Low-risk and high-risk subgroups identified using the recurrence model showed different disease-free survival (DFS) times (P<0.001) and the risk score of five PRGs was a factor of independence for recurrence in patients with PCa. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses suggested that these pathways, and comprising PRGs might be closely related to carcinogenesis and invasion of tumors, tumor microenvironment, and immune response. In conclusion, the expression signatures of PRGs play an important role in predicting PCa recurrence.https://www.frontiersin.org/articles/10.3389/fonc.2022.814912/fullpyroptosisprostate cancerrecurrenceimmunityprognosis
spellingShingle Chun Li
Chun Li
Chun Li
Chun Li
Jie Zhu
Hexi Du
Hexi Du
Hexi Du
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
Frontiers in Oncology
pyroptosis
prostate cancer
recurrence
immunity
prognosis
title Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
title_full Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
title_fullStr Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
title_full_unstemmed Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
title_short Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
title_sort identification of novel pyroptosis related gene signatures to predict prostate cancer recurrence
topic pyroptosis
prostate cancer
recurrence
immunity
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2022.814912/full
work_keys_str_mv AT chunli identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chunli identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chunli identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chunli identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT jiezhu identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT hexidu identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT hexidu identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT hexidu identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chaozhaoliang identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chaozhaoliang identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence
AT chaozhaoliang identificationofnovelpyroptosisrelatedgenesignaturestopredictprostatecancerrecurrence